Web of Science, ISC, CAS, Google Scholar

Document Type : Original Article


1 B.K. Mody Government Pharmacy College, New England Avenue, Piscataway, NJ, Near Aji Dam, Rajkot, Gujarat, India, Postal code: 360003

2 Amneal pharmaceutical LLC, Murray Road, Hanover, NJ 07936, USA


This research study aimed at developing and validating a simple, precise, accurate, specific and economical spectrophotometric method for simultaneous estimation of Ranolazine (RANO) and Metformin hydrochloride (MET) in synthetic mixture. This method is based on first order derivative spectroscopy.Ranolazine and Metformin hydrochloride exhibited absorbance at working wavelength 232.86 nm (Zero crossing point of Metformin hydrochloride) and 249.29 nm (zero crossing point of Ranolazine) respectively using water as a diluent. This method was validated as per ICH guideline. Linearity was established over the concentration range of 2-35 μg/mL both of Ranolazine and Metformin hydrochloride with correlation coefficients 0.999 and 0.998, respectively. Accuracy was obtained between 98.48-101.85% and 98.25-100.88% for Ranolazine and Metformin hydrochloride respectively. LOD and LOQ were found to be 0.08 μg/mL and 0.25 μg/mL for Ranolazine and 0.25 μg/mL and 0.77 μg/mL for Metformin hydrochloride, respectively.The results revealed that, the developed method was suitable for the routine analysis of determination of Ranolazine and Metformin hydrochloride in combine dosage form.
Keywords: Ranolazine; Metformin hydrochloride; First order derivative; UV spectrophotometry; ICH guideline

Graphical Abstract

First Order Derivative Spectrophotometric Estimation of Ranolazine and Metformin Hydrochloride in Synthetic Mixture


Main Subjects

[1] Teoh I. H., Banerjee M. Open Heart, 2018, 5:e000706
[2] Zack J., Berg J., Juan A., Pannacciulli N., Allard M., Gottwald M., Zhang H., Shao Y., Ben-Yehuda O., Jochelson P. Am. College Clin. Pharmacol., 2015, 4:121
[3] Tripathi K.D., Essential of Medical pharmacology; 7th Edn; Jaypee brother medical publishers, New Delhi, 2013, p 536
[4] Rang H. Dale J.M., Rang & Dales’s Pharmacology; 8th Edn; Elseveir publication, 2012, p 379
[5] RANOLAZINE, “Pubchem–Open chemistry database”, 10 October 2018,     https://pubchem.ncbi.nlm.nih.gov/compound/ranolazine
[6] Indian Pharmacopoeia, Government of India, Ministry of Health & Family Welfare; 8th Edition; Indian Pharmacopoeia Commission, Ghaziabad, 2018, Volume-II, Page No. 2544-2548
[7] US Pharmacopeia 39 NF 34, The United State Pharmacopoeial Convention Inc; Rockville, 2016, Volume- III, Page No. 4764-4766
[8] Japanese Pharmacopoeia, The Ministry of Health, Labourand Welfare; 17th Edition; Pharmaceuticals and Medical Devices Agency, 2016, Page No. 1222-1223
[9] British Pharmacopoiea, Medicines and Healthcare Products Regulatory Agency; 9th Edition; British Pharmacopoeial commission, London, 2018, Volume-II, Page No. 235-237
[10] Dange Y.D., Honmane S.M., Bhinge S.D., Salunkhe V.R., Jadge D.R. Indian J. Pharm. Edu. Res., 2017, 51:754
[11] Shukla R., Singh S., Patel J.R., Kare S., Yadav R. Asian J. Pharm. Pharmacol., 2016, 2:6
[12] Ganji R., Ramachandran D., Srinivas G., Gowardhane J., Rao Purnachanda., Int. J. Pharm. Bio. Sci., 2012, 2:356
[13] Bidada J., Gonjari I., Raut C., Bhutada C. Der Pharm. Chem., 2011, 3:1 
[14] Sharma A., Prakash D., Singh S. Int. J. Chemtech. Res., 2010, 2:1945
[15] Triveni D., Kumar G.V., Puranik S.B., Kumar N.S., Sridhar K.A. Int. Res. J. Pharm., 2012, 3:260
[16] Sulakshana S., Sankar R.V., Nageswarrao R., Harithanandini T., Reddy Y.D., Pushpalatha E. Int. J. Pharm.  Biol. Sci., 2015, 5:323
[17] Babu S., Sirisha R., Sowjanya S., Sravani S. J. Pharma. Creat., 2017, 4:102
[18] Godasu S.K., Sreenivas S.A. Int. J. Pharm. Sci. Res., 2017, 8:2223
[19] Sundar P.S., Tabassum I., Vasanthi R., Raja M.A., Rao K.N.V., Dutt K.R., Merugu M. Indo Am. J. Pharm., 2017, 3:223
[20] Afzal S.J.S., Asif M., Khan P.M.A.A.  J. Innov. Pharm and Bio. Sci. 2018, 5:1111
[21] Joseph L., George M. Saji S.T., Int. J. Med. Res. Pharm. Sci., 2017, 3:2126
[22] Sowmya S.P, Nirupama D., Mamatha N., Thangabalan B., Int. J. Innov. Pharm. Sci. Res., 2014, 2:1042
[23] Phani Kumar V., Sunandamma Y. Int. J. Pharm. Res., 2011, 1:542
[24] Lakshmi P.G., Haritha P.K., Agarwal N. Int. Res. J. Pharm. App. Sci., 2012, 2:217
[25] Kommineni V., Chowdary K.P.R., Prasad S.V.U.M. Indo Am. J. Pharm. Sci., 2017, 4:1109
[26] Premkumar J., Sudhakar T., Srikiran K. J. Chem. Pharm. Res., 2015, 7:346.
[27] Malati V., Reddy A.R., Mukkanti K., Suryanarayana M.V. Talanta, 2012, 97:563
[28] Guideline, I.H.T., Validation of analytical procedures: text and methodology Q2 (R1). International Conference on Harmonization, IFPMA, Geneva, Swizerland, 2005